A new heterologous fibrin sealant as scaffold to recombinant human bone morphogenetic protein-2 (rhBMP-2) and natural latex proteins for the repair of tibial bone defects

被引:37
作者
Machado, Eduardo Gomes [1 ]
Mardegan Issa, Joao Paulo [2 ]
Tocchini de Figueiredo, Fellipe Augusto [2 ]
dos Santos, Geovane Ribeiro [1 ]
Galdeano, Ewerton Alexandre [1 ]
Alves, Mariana Carla [1 ]
Chacon, Erivelto Luis [1 ]
Ferreira Junior, Rui Seabra [3 ]
Barraviera, Benedito [3 ]
da Cunha, Marcelo Rodrigues [1 ]
机构
[1] Sch Med Jundiai, Dept Morphol & Pathol, BR-13202550 Jundiai, SP, Brazil
[2] Univ Sao Paulo, Dent Sch Ribeirao Preto, Dept Morphol Stomatol & Physiol, BR-14040904 Ribeirao Preto, SP, Brazil
[3] Sao Paulo State Univ UNESP Univ Estadual Paulista, Ctr Study Venoms & Venomous Anim CEVAP, BR-18610307 Botucatu, SP, Brazil
关键词
Fibrin; Sealant; Scaffold; BMP-2; Natural latex; Protein P-1; SNAKE-VENOM; GLUE; CELL; COMPOSITES; VIABILITY; BMP-2;
D O I
10.1016/j.acthis.2015.03.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tissue engineering has special interest in bone tissue aiming at future medical applications Studies have focused on recombinant human bone morphogenetic protein-2 (rhBMP-2) and natural latex proteins due to the osteogenic properties of rhBMP-2 and the angiogenic characteristic of fraction 1 protein (P-1) extracted from the rubber tree Hevea brasiliensis. Furthermore, heterologous fibrin sealant (FS) has been shown as a promising alternative in regenerative therapies. The aim of this study was to evaluate these substances for the repair of bone defects in rats. A bone defect measuring 3 mm in diameter was created in the proximal metaphysis of the left tibia of 60 rats and was implanted with rhBMP-2 or P-1 in combination with a new heterologous FS derived from snake venom. The animals were divided into six groups: control (unfilled bone defect), rhBMP-2 (defect filled with 5 mu g rhBMP-2), P-1 (defect filled with 5 mu g P-1), FS (defect filled with 8 mu g FS), FS/rhBMP-2 (defect filled with 8 mu g FS and 5 mu g rhBMP-2), FS/P-1 (defect filled with 8 mu g FS and 5 mu g P-1). The animals were sacrificed 2 and 6 weeks after surgery. The newly formed bone projected from the margins of the original bone and exhibited trabecular morphology and a disorganized arrangement of osteocyte lacunae. Immunohistochemical analysis showed intense expression of osteocalcin in all groups. Histometric analysis revealed a significant difference in all groups after 2 weeks (p < 0.05), except for the rhBMP-2 and FS/rhBMP-2 groups (p > 0.05). A statistically significant difference (p < 0.05) was observed in all groups after 6 weeks in relation to the volume of newly formed bone in the surgical area. In conclusion, the new heterologous fibrin sealant was found to be biocompatible and the combination with rhBMP-2 showed the highest osteogenic and osteoconductive capacity for bone healing. These findings suggest a promising application of this combination in the regeneration surgery. (C) 2015 Elsevier GmbH. All rights reserved.
引用
收藏
页码:288 / 296
页数:9
相关论文
共 37 条
  • [1] Antigen-free bovine cancellous bone loaded with recombinant human bone morphogenetic protein-2 for the repair of tibial bone defects in goat model
    Li, Donghai
    Deng, Liqing
    Yang, Zhouyuan
    Xie, Xiaowei
    Kang, Pengde
    Tan, Zhen
    JOURNAL OF BIOMATERIALS APPLICATIONS, 2016, 30 (09) : 1322 - 1333
  • [2] The local cytokine and growth factor response to recombinant human bone morphogenetic protein-2 (rhBMP-2) after spinal fusion
    Koerner, John D.
    Markova, Dessislava Z.
    Schroeder, Greg D.
    Calio, Brian P.
    Shah, Anuj
    Brooks, Corbin W.
    Vaccaro, Alexander R.
    Anderson, D. Greg
    Kepler, Christopher K.
    SPINE JOURNAL, 2018, 18 (08) : 1424 - 1433
  • [3] An in vitro study of fibrin sealant as a carrier system for recombinant human bone morphogenetic protein (rhBMP)-9 for bone tissue engineering
    Fujioka-Kobayashi, Masako
    Mottini, Matthias
    Kobayashi, Eizaburo
    Zhang, Yufeng
    Schaller, Benoit
    Miron, Richard J.
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2017, 45 (01) : 27 - 32
  • [4] Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2
    Jung, RE
    Schmoekel, HG
    Zwahlen, R
    Kokovic, V
    Hammerle, CHF
    Weber, FE
    CLINICAL ORAL IMPLANTS RESEARCH, 2005, 16 (06) : 676 - 682
  • [5] Recombinant human bone morphogenetic protein-2 suspended in fibrin glue enhances bone formation during distraction osteogenesis in rabbits
    Li, Yunfeng
    Li, Rui
    Hu, Jing
    Song, Donghui
    Jiang, Xiaowen
    Zhu, Songsong
    ARCHIVES OF MEDICAL SCIENCE, 2016, 12 (03) : 494 - 501
  • [6] Release behavior and biological activity of recombinant human bone morphogenetic protein-2 from porous PLGA scaffold
    Zhu, HY
    Wu, QL
    Shentu, J
    Wang, HM
    Hu, YQ
    Zhu, KJ
    Liu, JH
    JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2005, 20 (03) : 271 - 278
  • [7] Efficacy of hydroxyapatite and fibrin sealant as carriers for bone morphogenetic protein-2 in maxilary sinus floor augmentation: a retrospective study
    Nam, J. W.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2024, 53 (09) : 795 - 801
  • [8] Repair of Rat Cranial Bone Defects with nHAC/PLLA and BMP-2-Related Peptide or rhBMP-2
    Li, Jingfeng
    Hong, Jijun
    Zheng, Qixin
    Guo, Xiaodong
    Lan, Shenghui
    Cui, Fuzhai
    Pan, Haitao
    Zou, Zhenwei
    Chen, Chao
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2011, 29 (11) : 1745 - 1752
  • [9] Combinatorial Effect of Stem Cells Derived from Mandible and Recombinant Human Bone Morphogenetic Protein-2
    Park, Jun-Beom
    Kim, Ki-Young
    Lee, Won
    Kim, Heesung
    Kim, Insoo
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2015, 12 (05) : 343 - 351
  • [10] Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration
    Yang, Hee Seok
    La, Wan-Geun
    Cho, Yong-Min
    Shin, Wangsoo
    Yeo, Guw-Dong
    Kim, Byung-Soo
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2012, 44 (05) : 350 - 355